A Phase 2 comparative study of Alenura
Latest Information Update: 06 Sep 2022
At a glance
- Drugs Alkalinized lidocaine/heparin (Primary)
- Indications Interstitial cystitis
- Focus Therapeutic Use
- 01 Sep 2022 According to Hyloris Pharmaceuticals media release, the company expect to initiate this trial later this year.
- 22 Dec 2021 New trial record
- 17 Dec 2021 According to Hyloris Pharmaceuticals media release, the company anticipates the start of a larger Phase 2 comparative study mid 2022 for which the results could be available by late 2023